Eucalyptus oil moving into OTC, quasi-drug, and personal care supply chains carries different specification requirements depending on the buyer’s regulatory category and target market. A cough lozenge manufacturer in the United States, a quasi-drug registrant in Japan, and a soap formulator working under IFRA limits each needs a different cut of the same oil: a defined 1,8-cineole percentage, a confirmed chemotype, and a paper trail that reaches back to the distillation batch. Getting these details wrong at the purchase order stage is a common reason first shipments get held for clarification. Our ユーカリエッセンシャルオイル（グロブルス） is supplied across these grades, sourced and documented to match each buyer’s category.

Exporters and buyers both benefit from settling these specifications before an order is placed rather than after a shipment lands. This eucalyptus oil sourcing guide walks through the technical reference data buyers ask for first, eucalyptus chemotype selection, cineole grading, Japan’s quasi-drug classification, storage and batch consistency, and the compliance documents that keep a bulk order moving through customs without delay.

Before requesting a quote, have four details ready: your target 1,8-cineole range, the intended product category (cosmetic, quasi-drug, or pharmaceutical-adjacent), the destination country, and the order volume. With these on hand, our export team can confirm the correct eucalyptus grade and prepare documentation matched to your import process.

見積もりを依頼する

Eucalyptus Oil Sourcing: Technical Specifications India Buyers Rely On

Buyers evaluating a new eucalyptus oil supplier typically start with a specification sheet before any sample changes hands. India’s eucalyptus oil, most of it grown and distilled in the Nilgiri hills of Tamil Nadu, has supplied export markets for decades and carries a well-documented set of reference parameters.

The Nilgiri eucalyptus oil industry supplies both domestic Indian demand and export markets, with production concentrated around Ooty, Coonoor, and the surrounding hill country where Eucalyptus globulus was first planted in the nineteenth century and later became a commercial oil crop. Export volumes from India compete with material grown in Australia, China, Spain, and Portugal, and buyers generally choose a supplier based on documented cineole content, consistent lead times, and total landed cost rather than country of origin alone.

Australia is eucalyptus oil’s country of origin botanically, and Australian-grown Eucalyptus globulus and Eucalyptus polybractea are also traded internationally, often for cineole content at the higher end of the range. These figures describe the general commercial grade and vary by batch within the ranges confirmed on each shipment’s paperwork; buyers should treat the COA and GC-MS report for their specific order as the governing document, not the general figures above.

Why 1,8-Cineole Content Defines Eucalyptus Oil Grade

1,8-cineole, also called eucalyptol, is the oxide that determines how a eucalyptus oil batch is graded and priced. Rectified Eucalyptus globulus oil is typically supplied at 70-75% or 80-85% cineole content under the ISO 770 standard, while crude, unrectified oil runs lower in cineole and serves different downstream uses.

• 70-75% cineole: common in soap, household fragrance, and general aromatherapy blending
• 80-85% cineole: preferred for OTC, quasi-drug, and pharmaceutical-adjacent formulations that need higher oxide purity
• Crude, unrectified oil: lower and more variable cineole content, typically reprocessed or sold for technical-grade use

Buyers should confirm which grade a supplier is quoting before comparing price per kilogram. A 70-75% grade and an 80-85% grade are not interchangeable in a quasi-drug formulation, even when both batches are labeled Eucalyptus globulus oil. Specification sheets should state the cineole range as a number, not a general grade name.

Cineole content also tracks with price. Buyers sometimes request the highest available percentage without checking whether their formulation needs it; an 80-85% grade purchased for a use case that only requires 70-75% adds cost without a functional benefit. Confirming the requirement with a formulation chemist before issuing a purchase order avoids this.

Eucalyptus globulus vs Other Chemotypes Used in Export Trade

Eucalyptus globulus is the species most often rectified for cineole content and the one referenced in ISO 770, but it is not the only eucalyptus oil moving through export trade. Eucalyptus radiata and Eucalyptus australiana also reach international buyers, generally for gentler aromatic profiles rather than high-cineole OTC applications.

Species and chemotype are confirmed through GC-MS analysis matched against reference chromatograms, supported by organoleptic evaluation. Cross-species blending shows up clearly on a chromatogram as unexpected peaks, for example elevated alpha-pinene or globulol outside the expected range for Eucalyptus globulus, which is one reason GC-MS remains the standard verification tool rather than relying on appearance or aroma alone.

Blending Eucalyptus globulus with a lower-cost, lower-cineole eucalyptus species to hit a target percentage on paper is a known shortcut in the wider trade, and it is one more reason GC-MS verification against a full reference chromatogram, not just a single cineole percentage, matters for buyers sourcing at scale.

Buyers comparing eucalyptus to other Myrtaceae-family oils with related oxide or phenolic chemistry often evaluate cajeput essential oil および tea tree essential oil alongside it, particularly for antimicrobial fragrance applications where cineole and terpinen-4-ol both play a role. Our earlier note on vetting bulk tea tree oil suppliers covers a parallel authentication process built around a different reference standard, ISO 4730.

How Japan’s Quasi-Drug Classification Affects Import Documentation

Japan’s Pharmaceutical and Medical Device Act splits personal care and topical products into cosmetics and quasi-drugs, and eucalyptus oil can appear in either category depending on the finished product’s claimed function. Under quasi-drug regulation in Japan, only formulations built around MHLW-approved active ingredients at defined doses can be marketed as quasi-drugs, which changes the documentation an importer needs to submit.

• Cosmetic-use eucalyptus oil generally follows standard cosmetic ingredient notification
• Quasi-drug formulations require ingredient-level support tied to the approved active ingredient list
• Eucalyptus oil referenced against Japanese Pharmacopoeia monographs gives quasi-drug registrants an additional identity and purity benchmark beyond a standard COA

Beyond the quasi-drug and cosmetic classification question, import shipments into Japan generally require Japanese-language labeling on the retail product, along with the standard import documentation package: invoice, packing list, and Certificate of Origin. Buyers should confirm current requirements with their own customs broker or regulatory affairs team, since labeling and notification rules are administered separately from the bulk ingredient shipment itself.

None of this replaces a review by a Japan-based regulatory consultant for a specific formulation. What an export supplier can control is accurate species identification, cineole content, and batch documentation, delivered early enough for the buyer’s regulatory team to work with it before a filing deadline.

GC-MS, COA, and IFRA Documentation Bulk Buyers Should Request

A complete eucalyptus oil documentation set includes a Certificate of Analysis confirming physical and chemical parameters, a GC-MS report showing the cineole percentage and other terpene components, and a Safety Data Sheet. Buyers formulating fragrance-facing products should also request confirmation against the relevant IFRA Standards category limit.

• COA: specific gravity, refractive index, optical rotation, and cineole percentage
• GC-MS: full terpene and oxide profile, specific to the batch shipped
• SDS: handling, storage, and transport classification
• IFRA compliance note: relevant for fragrance and cosmetic end uses, referenced by product category
• Allergen declaration: relevant where the finished product falls under EU cosmetic labeling rules

A GC-MS report is only useful when it is read against the buyer’s own specification range rather than treated as a pass or fail document on its own. Two batches can both carry a passing COA while sitting at opposite ends of an acceptable cineole range, and for a quasi-drug or pharmaceutical-adjacent formulation, that difference can matter.

The same documentation logic applies across the catalog. Our earlier note on GC-MS and IFRA reports for cardamom oil sourcing covers how buyers should read a chromatogram against a stated specification, and the same reading applies to eucalyptus oil. The full set of documentation formats we issue is outlined on our quality and certification documentation page.

Packaging, HS Code, and Export Logistics for Bulk Orders

Eucalyptus oil for bulk export is typically packed in food-or-pharma-grade drums or lined containers sized to the buyer’s volume, most often 25 kg, 180 kg, or ISO tank quantities for the largest orders. Correct HS code classification and complete export documentation reduce the chance of a customs hold on arrival.

• HS code: essential oils generally fall under HS heading 3301; the exact subheading depends on the destination country’s tariff schedule and should be confirmed with the buyer’s customs broker
• Shipping mode: sea freight for full-container and part-container volumes, air freight for smaller or time-sensitive orders
• Shipment documentation: commercial invoice, packing list, Certificate of Origin, COA, and SDS

Sample quantities, typically 100g to 1kg, generally ship by air courier and clear customs faster than a full commercial shipment, which makes them a practical first step before committing to a container-scale order. Full-container orders are planned around production and vessel schedules, so buyers with a fixed launch date should share their target delivery window early.

Full details on lead times, freight options, and port coverage are covered on our 国際配送オプション page. Buyers ordering for the first time should confirm packaging format and labeling requirements with their export contact before production begins, since relabeling after packing adds cost and delay.

Storage, Shelf Life, and Batch Consistency for Repeat Orders

Cineole-rich oils oxidize gradually when exposed to heat, light, and air, which is why storage conditions affect both shelf life and repeat-order consistency. Properly stored eucalyptus oil in a sealed container, kept cool and away from direct light, typically holds its specification for 2 to 3 years from the production date. Once a drum is opened and partially used, headspace air accelerates oxidation, so buyers working through a large drum over several months should transfer working quantities into smaller, fully sealed containers rather than repeatedly opening the original drum.

• Retained samples: each production batch is retained alongside its COA and GC-MS report for reference against future shipments
• Blending within specification: where a single distillation run falls outside the agreed cineole range, batches are blended to bring the pooled lot back within the buyer’s specified tolerance rather than shipped out of spec
• Repeat-order consistency: buyers on a standing order typically receive the same cineole range and packaging format across shipments, confirmed against the original approved sample

For buyers managing their own shelf life claims downstream, for example a quasi-drug product with its own labeled expiry date, requesting the production date and batch number on each Certificate of Analysis makes it possible to track raw material age against the finished product’s own shelf life calculation.

Distillation and export from South India follow a seasonal rhythm tied to the local eucalyptus harvest and monsoon logistics. Buyers placing large orders around the monsoon period, typically June through September, should build in extra lead time for inland transport from the Nilgiri hills to the nearest port, since heavy rainfall can affect road transport schedules in the growing region.

Does Eucalyptus Oil Qualify for Private Label and OEM Programs?

Eucalyptus oil is a common candidate for private label and OEM programs because the specification, meaning species, cineole grade, and documentation, can be locked in per buyer while packaging and branding stay flexible. Buyers supplying quasi-drug or pharmaceutical-adjacent markets typically request a fixed cineole range across repeat batches rather than a single one-off shipment.

Private label arrangements generally cover custom drum or bottle labeling, buyer-specific COA templates, and dedicated batch coding for traceability. Packaging options range from buyer-branded amber glass bottles for smaller retail-facing volumes to neutral or buyer-labeled drums for bulk industrial supply. Typical minimum order quantities for private label eucalyptus oil start around 100 kg for an established specification and scale from there depending on packaging complexity. Our private label and OEM programs are discussed case by case, since minimum order quantity and lead time depend on the cineole grade and packaging format requested.

Repeat buyers on multi-year contracts sometimes request an annual re-verification of species and cineole range even when packaging and pricing remain stable, particularly where the finished product carries its own regulatory registration tied to the raw material specification.

よくある質問

The questions below come up most often from OTC formulators, quasi-drug registrants, and cosmetic buyers evaluating eucalyptus oil for the first time. Each answer reflects current sourcing and regulatory practice rather than a guarantee tied to a specific batch or market.

Is eucalyptus oil classified as a quasi-drug ingredient in Japan?

Eucalyptus oil itself is not automatically a quasi-drug ingredient. Classification depends on the finished product’s formulation and claimed function under Japan’s Pharmaceutical and Medical Device Act. A product built around an MHLW-approved active ingredient at a defined dose may qualify as a quasi-drug, while the same oil used in a standard cosmetic follows cosmetic notification instead. A regulatory consultant familiar with the destination category should confirm the specific formulation.

What cineole percentage should OTC buyers request?

Most OTC and pharmaceutical-adjacent buyers request 80-85% cineole content, the higher of the two common rectified grades under ISO 770. Buyers should confirm the exact range against their own formulation requirements rather than assume a single percentage applies across every application, since some cosmetic and fragrance uses are formulated around the 70-75% grade instead, at a lower cost. Requesting the range in writing on the purchase order avoids ambiguity if a shipment is later queried.

Can eucalyptus oil be supplied under private label for cosmetic or quasi-drug brands?

Yes. Private label eucalyptus oil typically ships with buyer-specified drum or bottle labeling, a dedicated COA template, and batch coding tied to the buyer’s own lot numbering. Cineole grade and packaging format are agreed before production, and repeat-order programs generally lock in the same specification across batches for consistency.

What documents accompany a bulk eucalyptus oil shipment?

A standard shipment includes a Certificate of Analysis, a GC-MS report, a Safety Data Sheet, a Certificate of Origin, a commercial invoice, and a packing list. Buyers working toward quasi-drug or pharmaceutical registration in their destination market may also request Japanese Pharmacopoeia or regional pharmacopoeia cross-reference data where applicable.

Cineole specifications and quasi-drug classification rules are reviewed periodically on both the standards and regulatory side, most recently folded into the current Japanese Pharmacopoeia supplement cycle. Buyers building a long-term supply relationship benefit from confirming the current reference edition with their supplier at each new contract, rather than assuming a specification from a prior order still applies, especially across a multi-year supply agreement.

For a first order, a small sample set with matching COA and GC-MS documentation lets a formulation team verify cineole content against their own equipment and internal specification before committing to a full container. A sample review typically takes a formulation team one to two weeks, well ahead of a first production run. Request Samples to start that process.